Skip to main content
. 2020 Dec 1;71(Suppl 3):S222–S231. doi: 10.1093/cid/ciaa1320

Table 5.

Univariable and Multivariable Analysis of Factors Associated With Hospitalization Among Patients With Blood Culture–Confirmed Enteric Fever (Salmonella Typhi and Paratyphi A) Enrolled in the Surveillance for Enteric Fever in Asia Project (SEAP), by Country—Bangladesh, Nepal, and Pakistan, September 2016–September 2019

Bangladesh Nepal Pakistan
Univariable (n = 4868) Multivariablea (n = 3003) Univariable (n = 1595) Multivariablea (n = 519) Univariable (n = 2206 Multivariablea (n = 1548)
Age in years
 <2 2.82 (2.21, 3.60)* 5.51 (1.90, 16.01)* 1.74 (.67, 4.53) 3.19 (.41, 24.96) .83 (.62, 1.11) .70 (.48, 1.03)
 2–4 2.17 (1.80, 2.64)* 3.87 (1.35, 11.10)* .76 (.37, 1.55) 2.31 (.75, 7.15) .92 (.72, 1.17) .73 (.53, 1.02)
 5–15 1.61 (1.34, 1.93)* 3.10 (1.08, 8.90)* 1.47 (1.14, 1.89)* 3.10 (2.01, 4.80)* 1.00 (.80, 1.26) .99 (.73, 1.33)
 ≥16 Ref Ref Ref Ref Ref Ref
Gender
 Female Ref Ref Ref Ref Ref Ref
 Male 1.00 (.88, 1.14) .91 (.78, 1.07) .70 (.55, .86)* .78 (.51, 1.28) 1.09 (.92, 1.29) 1.16 (.93, 1.45)
Species
S. Paratyphi A Ref Ref Ref Ref Ref Ref
S. Typhi 1.67 (1.37, 2.03)* 1.43 (1.10, 1.84)* 1.51 (1.09, 2.11)* 1.58 (.91, 2.74) 2.41 (1.63, 3.56)* 1.70 (1.05, 2.74)*
Fluoroquinolone sensitivity
 Susceptible Ref Ref Ref Ref Ref Ref
 Reduced susceptibility 1.57 (.93, 2.63) 2.64 (1.27, 5.48)* .88 (.64, 1.22) .84 (.45, 1.59) 2.84 (1.81, 4.47)* 1.98 (1.18, 3.32)*
Third-generation cephalosporin sensitivityb
 Susceptible Ref Ref Ref Ref Ref Ref
 Resistant 2.07 (1.74, 2.47)* 1.78 (1.40, 2.27)*
Prior antibiotic use
 No Ref Ref Ref Ref Ref Ref
 Yes 1.75 (1.53, 1.99)* 1.32 (1.12, 1.56)* 1.62 (1.27, 2.07)* 1.33 (.61, 2.00) 1.78 (1.50, 2.11)* 2.05 (1.62, 2.58)*
Days from fever onset to hospital presentationc
 <3 days Ref Ref Ref Ref Ref Ref
 3–5 days 1.14 (.87, 1.49) 1.11 (.85, 1.46) 1.17 (.67, 2.06) 1.10 (.61, 2.00) .68 (.42, 1.07) .61 (.38, .99)*
 6–9 days 2.04 (1.55, 2.69)* 1.87 (1.40, 2.47)* 2.86 (1.56, 5.25)* 2.53 (1.32, 4.85)* 1.53 (.97, 2.43) 1.17 (.72, 1.90)
 ≥10 days 2.70 (1.89, 3.87)* 2.55 (1.76, 3.69)* 2.46 (1.21, 5.01)* 2.31 (1.08, 4.92)* 3.67 (2.27, 5.93)* 2.47 (1.50, 4.14)*

Data are presented as ORs (95% CI). *P < .05.

Abbreviations: CI, confidence interval; OR, odds ratio; Ref, reference.

aMultivariable models include patients recruited from SEAP hospitals only.

bCephalosporin resistance only detected in Pakistan.

cFor SEAP hospital patients only; data not available for laboratory network patients.